Effect of Nitric Oxide on Naphthoquinone Toxicity in Endothelial Cells: Role of Bioenergetic Dysfunction and Poly(ADP-ribose) Polymerase Activation

被引:23
|
作者
Broniowska, Katarzyna A. [1 ]
Diers, Anne R. [1 ]
Corbett, John A. [2 ]
Hogg, Neil [1 ]
机构
[1] Med Coll Wisconsin, Dept Biophys, Redox Biol Program, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
OXIDATIVE STRESS; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; CELLULAR BIOENERGETICS; SUPEROXIDE GENERATION; NITROSATIVE STRESS; INDUCED APOPTOSIS; S-NITROSOTHIOLS; CYTO-TOXICITY; REDOX STATUS;
D O I
10.1021/bi400342t
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When produced at physiological levels, reactive oxygen species (ROS) can act as signaling molecules to regulate normal vascular function. Produced under pathological conditions, ROS can contribute to the oxidative damage of cellular components (e.g., DNA and proteins) and trigger cell death. Moreover, the reaction of superoxide with nitric oxide (NO) produces the strong oxidant peroxynitrite and decreases NO bioavailability, both of which may contribute to activation of cell death pathways. The effects of ROS generated from the 1,4-naphthoquinones alone and in combination with NO on the activation status of poly(ADP-ribose) polymerase (PARP) and cell viability were examined. Treatment with redox cycling quinones activates PARP, and this stimulatory effect is attenuated in the presence of NO. Mitochondria play a central role in cell death signaling pathways and are a target of oxidants. We show that simultaneous exposure of endothelial cells to NO and ROS results in mitochondrial dysfunction, ATP and NAD(+) depletion, and cell death. Alone, NO and ROS have only minor effects on cellular bioenergetics. Further, PARP inhibition does not attenuate reduced cell viability or mitochondrial dysfunction. These results show that concomitant exposure to NO and ROS impairs energy metabolism and triggers PARP-independent cell death. While superoxide-mediated PARP activation is attenuated in the presence of NO, PARP inhibition does not modify the loss of mitochondrial function or adenine and pyridine nucleotide pools and subsequent bioenergetic dysfunction. These findings suggest that the mechanisms by which ROS and NO induce endothelial cell death are closely linked to the maintenance of mitochondrial function and not overactivation of PARP.
引用
收藏
页码:4364 / 4372
页数:9
相关论文
共 50 条
  • [41] Diabetes-induced cerebrovascular dysfunction: Role of poly(ADP-ribose) polymerase
    Arrick, Denise M.
    Sharpe, Glenda M.
    Sun, Hong
    Mayhan, William G.
    MICROVASCULAR RESEARCH, 2007, 73 (01) : 1 - 6
  • [42] Poly (ADP-ribose) Polymerase Inhibition Improves Endothelial Dysfunction Induced by Hyperhomocysteinemia in Rats
    Xian Yu
    Xiang Cheng
    Jiang-jiao Xie
    Meng-yang Liao
    Rui Yao
    Yong Chen
    Ying-jun Ding
    Ting-ting Tang
    Yu-hua Liao
    Cardiovascular Drugs and Therapy, 2009, 23 : 121 - 127
  • [43] Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass
    Szabó, G
    Soós, P
    Bährle, S
    Zsengellér, Z
    Flechtenmacher, C
    Hagl, S
    Szabó, C
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (05) : 825 - 832
  • [44] Role of poly(ADP-ribose) polymerase activation in the pathogenesis of endothelial injury induced by high glucose in vitro
    Virag, L
    Soriano, FG
    Jagtap, P
    Mabley, J
    Szabo, E
    Liaudet, L
    Hoyt, D
    Murthy, K
    Salzman, A
    Southan, G
    Szabo, C
    FASEB JOURNAL, 2001, 15 (04): : A216 - A216
  • [45] Poly (ADP-ribose) Polymerase Inhibition Improves Endothelial Dysfunction Induced by Hyperhomocysteinemia in Rats
    Yu, Xian
    Cheng, Xiang
    Xie, Jiang-jiao
    Liao, Meng-yang
    Yao, Rui
    Chen, Yong
    Ding, Ying-jun
    Tang, Ting-ting
    Liao, Yu-hua
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (02) : 121 - 127
  • [46] Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase
    Soriano, FG
    Pacher, P
    Mabley, J
    Liaudet, L
    Szabó, C
    CIRCULATION RESEARCH, 2001, 89 (08) : 684 - 691
  • [47] Inhibition of poly(ADP-ribose) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species
    Sidorkina, O
    Espey, MG
    Miranda, KM
    Wink, DA
    Laval, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 (11) : 1431 - 1438
  • [48] Effects of deltamethrin on nitric oxide synthase and poly(ADP-ribose) polymerase in rat brain
    Wu, AG
    Liu, YG
    BRAIN RESEARCH, 1999, 850 (1-2) : 249 - 252
  • [49] Nitric oxide inhibits DNA synthesis and induces activation of poly(ADP-ribose) polymerase in cultured rat hepatocytes
    Dalmau, M
    Joaquin, M
    Nakamura, T
    Bartrons, R
    Gil, J
    EXPERIMENTAL CELL RESEARCH, 1996, 228 (01) : 14 - 18
  • [50] Role of the activation of the nuclear enzyme poly(ADP-ribose) polymerase in the pathogenesis of periodontitis
    Lohinai, Z
    Mabley, JG
    Fehér, E
    Marton, A
    Komjáti, K
    Szabó, C
    JOURNAL OF DENTAL RESEARCH, 2003, 82 (12) : 987 - 992